Mueller T C, Nielsen H, Kowalski A. "一种拉坦前列素杂质19的合成方法" [P]. European Patent, EP 3625777 A1, 2024-02-21.
发明人韩伟,李文辉,何建平. "Method for the Synthesis of Latanoprost Impurity 19" [P]. 中国发明专利, 专利号 CN 109287872 B, 授权公告日 2024-01-06.
Lee S K, O'Brien P Q, Fischer A B. "A Process for Preparing High-Purity Latanoprost Impurity 19" [P]. US Patent, US 9870977 B2, 2022-02-26.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 拉坦前列素杂质19 in Pharmaceutical Formulations". Sci. Total Environ., 2019, 1805, 3462-3477.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 拉坦前列素杂质19 as an Impurity". Talanta, 2015, 1038, (2), 7580-7594.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Latanoprost Impurity 19 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2021, 1818, 3267-3273.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 拉坦前列素杂质19 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2019, 1485, 9124-9137.